Diabetes
Conditions
Interventions
For patients using Nanopass Needle II 34G x 4 mm Use BD Micro Fine Pro 32G x 4 mm 5 times, Conduct a questionnaire after use.
Sponsors
Murakami Memorial Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: * Patients with type 1 or 2 diabetes. * Those who are using a pen-type insulin injector to inject insulin. * Those who are willing to complete all test procedures. * Those that can enter the results on the test survey form. * Those who understand the contents of informed consent and are willing to participate in this exam.
Exclusion criteria
Exclusion criteria: * Pregnancy, or those suspected of it. * Breastfeeding. * Those with severe neurological disease. * Those in physical condition who can not carry out the test procedure (such as patients who can not inject themselves). * Those judged by the responsible doctor or his / her doctor that there is a risk for participation in this study. * Patients who have the potential to be confused in the interpretation of test results. Or what I had. * Employees of pharmaceutical companies or medical equipment companies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Taste of needle which we want to use from now on | — |
Countries
Japan
Contacts
Public ContactYouko Ochi
Murakami Memorial Hospital Pharmaceutical department
Outcome results
None listed